000 | 01261 a2200325 4500 | ||
---|---|---|---|
005 | 20250517162055.0 | ||
264 | 0 | _c20171016 | |
008 | 201710s 0 0 eng d | ||
022 | _a2359-4292 | ||
024 | 7 |
_a10.1590/2359-3997000000267 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaciel, Léa Maria Zanini | |
245 | 0 | 0 |
_aMedullary thyroid carcinoma - Adverse events during systemic treatment: risk-benefit ratio. _h[electronic resource] |
260 |
_bArchives of endocrinology and metabolism _c |
||
300 |
_a398-402 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnilides _xadverse effects |
650 | 0 | 4 |
_aCarcinoma, Neuroendocrine _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPiperidines _xadverse effects |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aPyridines _xadverse effects |
650 | 0 | 4 |
_aQuinazolines _xadverse effects |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aThyroid Neoplasms _xdrug therapy |
700 | 1 | _aMagalhães, Patrícia Künzle Ribeiro | |
773 | 0 |
_tArchives of endocrinology and metabolism _gvol. 61 _gno. 4 _gp. 398-402 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1590/2359-3997000000267 _zAvailable from publisher's website |
999 |
_c27319974 _d27319974 |